Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
524404 | BSE
5.05
3.05%
Healthcare
Drug Manufacturers - Major
31/03/2023
04/12/2023
170.65
169.80
172.00
167.15
Marksans Pharma Limited together with its subsidiaries researches develops manufactures markets distributes and sells generic pharmaceutical formulations in North America Europe the United Kingdom Australia New Zealand and internationally. The company offers products in the analgesic anti-inflammatory benign prostatic hyperplasia epilepsy hyperparathyroidism diabetic and antidiabetic pain management neurology antacid hormonal antifungal antiulcerative cardiovascular and central nervous system vitamin cough and cold dermatology gastrointestinal gynecology cephalosporin injectable antibacterial hypertension oncology and antibiotics and anti-allergic therapeutic areas. It also provides contract research and manufacturing services; and develops and out-licenses patented products. The company was incorporated in 1992 and is headquartered in Mumbai India.
View LessPositive Momentum
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
64.3%1 month
60.7%3 months
44.6%6 months
45.4%12.05
0
2.75
0.26
0.20
7.02
1.44
0
2.79B
21.36B
256.17M
0.20
18.23
92.10
39.00
25.47
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
36.35
Range1M
59.55
Range3M
78.15
Rel. volume
0.34
Price X volume
32.29M